Tech Company Financing Transactions

Amulet Pharmaceuticals Funding Round

On 1/18/2007, Amulet Pharmaceuticals raised $1.7 million in financing from Wilmington Investor Network.

Transaction Overview

Announced On
1/18/2007
Transaction Type
Venture Equity
Amount
$1,700,000
Round
Undisclosed
Investors
Proceeds Purpose
"The infusion of capital will enable us to accelerate our growth and commercialization strategy -- focusing on securing license agreements," said CEO Craig Liddell, Ph.D.

Company Information

Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
One Research Ct. 450
Rockville, MD 20850
USA
Email Address
Overview
Amulet was founded in 2001 by Dr. Robert Raulli Ph.D., a leader in Nitric Oxide based therapeutics. During the first 3 years of operations, Amulet developed it's own novel composition--of-matter intellectual property (NORTECH) and began segmenting it's NORTECH technology into dozens of well defined markets.
Profile
Amulet Pharmaceuticals LinkedIn Company Profile
Social Media
Amulet Pharmaceuticals Company Twitter Account
Company News
Amulet Pharmaceuticals News
Facebook
Amulet Pharmaceuticals on Facebook
YouTube
Amulet Pharmaceuticals on YouTube

Management Team

Title
Name
Email & Social
Chairman
Carlos Parajon
  Carlos Parajon LinkedIn Profile  Carlos Parajon Twitter Account  Carlos Parajon News  Carlos Parajon on Facebook


 

 

Browse more venture capital transactions:

Prev: 1/18/2007: meebo venture capital transaction
Next: 1/18/2007: Workshare venture capital transaction

 

Share this article

 


News on VC Transactions

We do our best to document funding rounds that are announced publicly. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary